Literature DB >> 14625879

Mood induction with facial expressions of emotion in patients with generalized anxiety disorder.

Shikha Srivastava1, Hari O Sharma, Manas K Mandal.   

Abstract

Patients with general anxiety disorder (GAD), anxiety prone subjects, and normal controls (n=30, N=90) were subjected to happy and sad mood induction conditions using facial expressions of emotion of varied intensity. Following mood induction, subjects were required to judge their mood state on two scales: the Positive and Negative Affect Scale and the Emotional Self Rating Scale. In general, the anxiety groups showed more sensitivity to the sad mood induction condition. However, the anxiety groups had a higher subjective rating for positive than negative emotions during the happy mood induction condition. These findings suggest the efficacy of the mood induction procedures in anxiety disorders. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14625879     DOI: 10.1002/da.10128

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  3 in total

1.  Reward learning in pediatric depression and anxiety: preliminary findings in a high-risk sample.

Authors:  Bethany H Morris; Lauren M Bylsma; Ilya Yaroslavsky; Maria Kovacs; Jonathan Rottenberg
Journal:  Depress Anxiety       Date:  2015-03-31       Impact factor: 6.505

2.  Motivations for Prescription Drug Misuse Related to Mental Health Problems in Adults.

Authors:  Tess K Drazdowski; Marya Schulte; Kate B Wolitzky-Taylor; Holle Schaper; Jason E Chapman
Journal:  Subst Use Misuse       Date:  2021-12-14       Impact factor: 2.164

3.  Neural Responsiveness to Reward as an Index of Depressive Symptom Change Following Cognitive-Behavioral Therapy and SSRI Treatment.

Authors:  Katie L Burkhouse; Stephanie M Gorka; Heide Klumpp; Amy E Kennedy; Shannon Karich; Jennifer Francis; Olusola Ajilore; Michelle G Craske; Scott A Langenecker; Stewart A Shankman; Greg Hajcak; K Luan Phan
Journal:  J Clin Psychiatry       Date:  2018-06-12       Impact factor: 4.384

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.